Ossium Health, Extremity Medical Team Up on OssiGraft Bone Matrix Distribution

Ossium Health has reached a collaborative agreement with Extremity Medical to disseminate its OssiGraft Viable Bone Matrix throughout the United States.  

A viable bone matrix (VBM) allograft, OssiGraft is derived from the vertebral bones of organ donors and is used in orthopedic surgery to reconstruct or repair musculoskeletal defects or injuries. OssiGraft donors must meet stringent criteria for both cell therapies and tissue products. The product is derived from a younger donor demographic than other bone allografts on the market and is characterized by a high cancellous bone ratio for optimal bone healing.
 
“Extremity Medical shares Ossium’s ambition to apply engineering principles in developing creative solutions that enhance human health. With the development of OssiGraft, we’re expanding the impact of each donor’s gift even further and advancing patient care solutions,” Ossium Health President/Co-Founder Kevin Caldwell said.

Ossium Health employs rigorous screening, testing, and processing controls, exceeding regulatory requirements. Ossium uses of a best-in-class decontamination process for the finished product.
 
Extremity Medical also has successfully completed the initial OssiGraft cases. The product is available now to U.S. surgeons.

“Extremity Medical has over a decade of experience in providing solutions for the orthopedic surgeon and this partnership with Ossium builds on our tradition of offering the most advanced products to help drive better clinical outcomes,” Extremity Medical CEO Matthew Lyons stated.

Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop biological therapies for hematologic diseases, solid organ transplant rejection, and orthopedic injuries. Founded in 2016, the company’s manufacturing facility is registered with the U.S. Food and Drug Administration and its laboratory is certified under the Clinical Laboratory Improvement Amendment (CLIA).
 
Founded in 2008, Extremity Medical LLC is a privately held medical device company based in Parsippany, N.J., that develops implants and instruments for upper and lower-extremity orthopedic procedures, including fusion and motion preservation. Extremity Medical is focused on developing solutions for challenging cases that promote better outcomes, especially in patients with poor bone quality.